Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Adlbrecht

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Journal of Clinical Medicine|November 13, 2021
Identifying Patients without a Survival Benefit following Transfemoral and Transapical Transcatheter Aortic Valve ReplacementDaniela Geisler, Piotr Nikodem Rudziński, Waseem Hasan, et al.
Thrombosis and Haemostasis|September 6, 2003
High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertensionDiana Bonderman, Peter L Turecek, Johannes Jakowitsch, et al.
Wiener Klinische Wochenschrift|May 4, 2022
Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies : Position paper of the Heart Failure Working Group of the Austrian Society of CardiologyJutta Bergler-Klein, Peter P Rainer, Markus Wallner, et al.
Neurocritical Care|August 3, 2021
Prediction of Neurological Recovery After Cardiac Arrest Using Neurofilament Light Chain is Improved by a Proteomics-Based Multimarker PanelRaphael Wurm, Henrike Arfsten, Besnik Muqaku, et al.
Blood|April 4, 2002
Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaqueDiana Bonderman, Alexander Teml, Johannes Jakowitsch, et al.
European Heart Journal|August 15, 2008
Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volumeChristopher Adlbrecht, Spyridoula Kommata, Martin Hülsmann, et al.
European Heart Journal. Acute Cardiovascular Care|January 4, 2017
Non-occlusive mesenteric ischaemia in out of hospital cardiac arrest survivorsRaphael Wurm, Anna Cho, Henrike Arfsten, et al.
Journal of Personalized Medicine|November 27, 2021
A Sneak-Peek into the Physician's Brain: A Retrospective Machine Learning-Driven Investigation of Decision-Making in TAVR versus SAVR for Young High-Risk Patients with Severe Symptomatic Aortic StenosisEna Hasimbegovic, Laszlo Papp, Marko Grahovac, et al.
European Journal of Clinical Investigation|January 12, 2021
The Iliofemoral tortuosity score predicts access and bleeding complications during transfemoral transcatheter aortic valve replacement: DataData from the VIenna Cardio Thoracic aOrtic valve registrY (VICTORY)Markus Mach, Thomas Poschner, Waseem Hasan, et al.
Plos One|June 21, 2017
Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registryMaximilian Tscharre, Florian Egger, Matthias Machata, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Journal of Clinical Medicine|November 13, 2021
Identifying Patients without a Survival Benefit following Transfemoral and Transapical Transcatheter Aortic Valve ReplacementDaniela Geisler, Piotr Nikodem Rudziński, Waseem Hasan, et al.
Thrombosis and Haemostasis|September 6, 2003
High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertensionDiana Bonderman, Peter L Turecek, Johannes Jakowitsch, et al.
Wiener Klinische Wochenschrift|May 4, 2022
Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies : Position paper of the Heart Failure Working Group of the Austrian Society of CardiologyJutta Bergler-Klein, Peter P Rainer, Markus Wallner, et al.
Neurocritical Care|August 3, 2021
Prediction of Neurological Recovery After Cardiac Arrest Using Neurofilament Light Chain is Improved by a Proteomics-Based Multimarker PanelRaphael Wurm, Henrike Arfsten, Besnik Muqaku, et al.
Blood|April 4, 2002
Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaqueDiana Bonderman, Alexander Teml, Johannes Jakowitsch, et al.
European Heart Journal|August 15, 2008
Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volumeChristopher Adlbrecht, Spyridoula Kommata, Martin Hülsmann, et al.
European Heart Journal. Acute Cardiovascular Care|January 4, 2017
Non-occlusive mesenteric ischaemia in out of hospital cardiac arrest survivorsRaphael Wurm, Anna Cho, Henrike Arfsten, et al.
Journal of Personalized Medicine|November 27, 2021
A Sneak-Peek into the Physician's Brain: A Retrospective Machine Learning-Driven Investigation of Decision-Making in TAVR versus SAVR for Young High-Risk Patients with Severe Symptomatic Aortic StenosisEna Hasimbegovic, Laszlo Papp, Marko Grahovac, et al.
European Journal of Clinical Investigation|January 12, 2021
The Iliofemoral tortuosity score predicts access and bleeding complications during transfemoral transcatheter aortic valve replacement: DataData from the VIenna Cardio Thoracic aOrtic valve registrY (VICTORY)Markus Mach, Thomas Poschner, Waseem Hasan, et al.
Plos One|June 21, 2017
Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registryMaximilian Tscharre, Florian Egger, Matthias Machata, et al.
Pageof 7